Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene.

Evans D, Bode A, von der Lippe G, Beil FU, Mann WA.

Eur J Med Res. 2011 Feb 24;16(2):79-84.

2.

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.

Evans D, Seedorf U, Beil FU.

Clin Genet. 2005 Oct;68(4):369-72.

PMID:
16143024
3.

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.

Henneman P, van der Sman-de Beer F, Moghaddam PH, Huijts P, Stalenhoef AF, Kastelein JJ, van Duijn CM, Havekes LM, Frants RR, van Dijk KW, Smelt AH.

Eur J Hum Genet. 2009 May;17(5):620-8. doi: 10.1038/ejhg.2008.202. Epub 2008 Nov 26.

4.

The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.

Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH.

Clin Chim Acta. 2009 Apr;402(1-2):83-7. doi: 10.1016/j.cca.2008.12.024. Epub 2008 Dec 31.

5.

[Association of apolipoprotein A5 gene -1131T/C polymorphism with serum lipids and carotid intima-media thickness in patients with type 2 diabetes mellitus].

Qiao Y, Liu R, Tian HM, Liu Y, Qiang O, Liu BW.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Nov;39(6):965-8, 999. Chinese.

PMID:
19253837
6.
7.

Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.

Chien KL, Hsu HC, Chen YC, Su TC, Lee YT, Chen MF.

Transl Res. 2009 Sep;154(3):133-41. doi: 10.1016/j.trsl.2009.06.005. Epub 2009 Jul 9.

PMID:
19665689
8.

The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.

Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, Olivieri O.

Atherosclerosis. 2007 Apr;191(2):409-17. Epub 2006 May 8.

PMID:
16682041
9.

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

van der Vleuten GM, Isaacs A, Zeng WW, ter Avest E, Talmud PJ, Dallinga-Thie GM, van Duijn CM, Stalenhoef AF, de Graaf J.

Biochim Biophys Acta. 2007 Jan;1772(1):81-8. Epub 2006 Oct 26.

10.

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Yin RX, Li YY, Lai CQ.

Lipids Health Dis. 2011 Aug 19;10:140. doi: 10.1186/1476-511X-10-140.

11.

Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.

Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH, Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley AT.

BMC Med Genet. 2006 Oct 10;7:76.

12.

Mutation screening of the APOA5 gene in subjects with coronary artery disease.

Soufi M, Sattler AM, Kurt B, Schaefer JR.

J Investig Med. 2012 Oct;60(7):1015-9. doi: 10.2310/JIM.0b013e3182686918.

PMID:
22914599
13.

Association of apolipoprotein A5 gene promoter region -1131T>C with risk of stroke in Han Chinese.

Li X, Su D, Zhang X, Zhang C.

Eur J Intern Med. 2011 Feb;22(1):99-102. doi: 10.1016/j.ejim.2010.07.012. Epub 2010 Aug 14.

PMID:
21238903
14.

Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.

Can Demirdöğen B, Şahin E, Türkanoğlu Özçelik A, Bek S, Demirkaya Ş, Adali O.

Mol Biol Rep. 2012 Dec;39(12):10459-68. doi: 10.1007/s11033-012-1926-z. Epub 2012 Oct 13.

PMID:
23065249
15.

Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.

Niculescu LS, Vlădică M, Sima AV.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):587-91. doi: 10.1016/j.bbrc.2009.11.103. Epub 2009 Nov 20.

PMID:
19932084
16.

-1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.

Sóter MO, Gomes KB, Fernandes AP, Carvalho Md, Pinheiro PS, Bosco AA, Silva DD, Sousa MO.

Mol Biol Rep. 2012 Jul;39(7):7541-8. doi: 10.1007/s11033-012-1588-x. Epub 2012 Feb 19.

PMID:
22350263
17.

Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.

Di Taranto MD, Staiano A, D'Agostino MN, D'Angelo A, Bloise E, Morgante A, Marotta G, Gentile M, Rubba P, Fortunato G.

Mol Cell Probes. 2015 Feb;29(1):19-24. doi: 10.1016/j.mcp.2014.10.002. Epub 2014 Oct 13.

PMID:
25308402
18.

The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.

Dorfmeister B, Cooper JA, Stephens JW, Ireland H, Hurel SJ, Humphries SE, Talmud PJ.

Biochim Biophys Acta. 2007 Mar;1772(3):355-63. Epub 2006 Dec 5.

19.

Supplemental Content

Support Center